Sotabase
Home
Researchers
Career
·
Learning And Development Program Manager
,
LaunchDarkly
2024–
·
Imaging Scientist @ Sanofi
,
Sanofi
Publications
(54)
A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy.
Chest · 2006
91
cited
Phase II Randomized Trial of Erlotinib or Vinorelbine in Chemonaive, Advanced, Non-small Cell Lung Cancer Patients Aged 70 Years or Older
Journal of Thoracic Oncology · 2012
59
cited
Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.
Annals of Oncology · 2002
58
cited
Tuberculous subcutaneous abscess: an analysis of seven cases.
Tubercle and Lung Disease · 1996
58
cited
Eight-Month Prospective Study of 14 Patients With Hospital-Acquired Severe Acute Respiratory Syndrome
Mayo Clinic proceedings · 2004
49
cited
Latent TB infection in newly diagnosed lung cancer patients - A multicenter prospective observational study.
Lung Cancer · 2014
33
cited
A Phase II Randomized Trial of Gefitinib Alone or with Tegafur/Uracil Treatment in Patients with Pulmonary Adenocarcinoma Who had Failed Previous Chemotherapy
Journal of Thoracic Oncology · 2011
32
cited
Exploring the efficacy of a case management model using DOTS in the adherence of patients with pulmonary tuberculosis.
Journal of Clinical Nursing · 2008
28
cited
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated
British Journal of Cancer · 2004
26
cited
Usefulness of pig-tail catheter for palliative drainage of malignant pleural effusions in cancer patients
Supportive Care in Cancer · 2000
26
cited
Erlotinib has better efficacy than gefitinib in adenocarcinoma patients without EGFR-activating mutations, but similar efficacy in patients with EGFR-activating mutations.
Experimental and Therapeutic Medicine · 2012
22
cited
A phase II study of single-agent docetaxel chemotherapy for non-small cell lung cancer.
Japanese Journal of Clinical Oncology · 2000
21
cited
Second-Line Therapy for Elderly Patients with Non-small Cell Lung Cancer Who Failed Previous Chemotherapy Is as Effective as for Younger Patients
Journal of Thoracic Oncology · 2010
20
cited
A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan.
Lung Cancer · 2007
18
cited
Management of hospital-acquired severe acute respiratory syndrome with different disease spectrum.
Journal of the Chinese Medical Association · 2003
18
cited
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.
Lung Cancer · 2003
18
cited
Tuberculous subcutaneous abscesses developing during chemotherapy for pulmonary tuberculosis.
Scandinavian Journal of Infectious Diseases · 1993
18
cited
A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly.
Lung Cancer · 2008
17
cited
Third‐line or fourth‐line chemotherapy in non‐small‐cell lung cancer patients with relatively good performance status
Journal of the Chinese Medical Association · 2011
17
cited
A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated.
Lung Cancer · 2005
16
cited
Show all 54 papers →
Sotabase
Jennifer Shih | Researcher Profile | Sotabase | Sotabase